Inhibition of ascorbic acid-induced modifications in lens proteins by peptides

被引:3
作者
Argirova, M
Argirov, O
机构
[1] Inst Med, Dept Chem & Biochem, Plovdiv 4002, Bulgaria
[2] Univ Missouri, Dept Ophthalmol, Columbia, MO 65201 USA
关键词
glycation; cataract; ascorbic acid; crystallins; inhibitors; dipeptides; aspartame; carnosine;
D O I
10.1002/psc.451
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of three dipeptides L-phenylalanyl-glycine, glycyl-L-phenylalanine, and aspartame (L-aspartyl-L-phenylalanine, methyl ester) as inhibitors of the ascorbic acid-induced modifications in lens proteins were studied. Their efficiency was compared to that of two known inhibitors - aminoguanidine and carnosine. The tested dipeptides diminished protein carbonyl content by 32-58% and most moderated the formation of chromophores, as measured by the absorbency at 325 nm of the glycated proteins. The appearance of non-tryptophan fluorescence (excitation 340 nm/emission 410 nm) was observed for proteins glycated with ascorbic acid. All of the dipeptides examined, as well as aminoguanidine, decreased this glycation-related fluorescence. The potential inhibitors prevented the intensive formation of very high molecular weight aggregates. A competitive mechanism of their inhibitory effect was proposed, based on the reactivity of individual substances toward ascorbic acid. These findings indicate that they have a potential for use as alternatives for aminoguanidine as an anti-glycation agent. Copyright (C) 2003 European Peptide Society and John Wiley Sons, Ltd.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 34 条
[1]   The glycation of bovine lens beta(L)-, beta(S)- and gamma-crystallins demonstrated by isoelectric focusing and lectin staining [J].
Ahrend, MHJ ;
Bours, J .
EXPERIMENTAL EYE RESEARCH, 1997, 65 (05) :711-715
[2]   Formation of advanced glycation endproducts from low molecular weight model compounds [J].
Argirova, MD ;
Kerina, II ;
Argirov, OK .
BIOORGANIC CHEMISTRY, 1999, 27 (06) :443-450
[3]   Metformin reduces systemic methylglyoxal levels in type 2 diabetes [J].
Beisswenger, PJ ;
Howell, SK ;
Touchette, AD ;
Lal, S ;
Szwergold, BS .
DIABETES, 1999, 48 (01) :198-202
[4]  
BLAKYTNY R, 1992, EXP EYE RES, V54, P509
[5]   Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine [J].
Booth, AA ;
Khalifah, RG ;
Hudson, BG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (01) :113-119
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Carnosine reacts with a glycated protein [J].
Brownson, C ;
Hipkiss, AR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (10) :1564-1570
[8]   Does vitamin C act as a pro-oxidant under physiological conditions? [J].
Carr, A ;
Frei, B .
FASEB JOURNAL, 1999, 13 (09) :1007-1024
[9]   Prevention of lens protein glycation by taurine [J].
Devamanoharan, PS ;
Ali, AH ;
Varma, SD .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 177 (1-2) :245-250
[10]   Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins [J].
Fu, SL ;
Fu, MX ;
Baynes, JW ;
Thorpe, SR ;
Dean, RT .
BIOCHEMICAL JOURNAL, 1998, 330 :233-239